Is Long-Term Ginkgo Biloba Use Safe?

Who actually asks this question

The question about the long-term safety of Ginkgo biloba usually comes from two people. The first is 30-45 years old, bought a jar a few months ago, feels fine, and wants to know whether it is alright to simply keep going. The second is buying it for a parent and wants to know that it will not break anything - especially if the parent is already on prescription medication.

The answer is unusual in one respect: ginkgo has better long-term safety data than most supplements. Not because anyone set out to study a supplement, but because two very large clinical trials gave thousands of older adults a standardised ginkgo extract for several years in a row. Those trials did not find what they were looking for. Precisely for that reason, something more valuable was left behind: a multi-year safety profile you can actually read.

In this article we look at what "long-term" meant in those trials, what exactly was seen on safety, where the bleeding story came from, who should be cautious, and how Estonia's thin ginkgo selection affects the decision in practice.

Prices in this article are MaxFit prices at the time of writing and they change.

What "long-term" actually means in the research

Most supplement studies run for 8-12 weeks. With ginkgo there are two exceptions in an entirely different weight class.

The Ginkgo Evaluation of Memory (GEM) trial enrolled roughly 3,000 people aged at least 72 and gave them a standardised extract at 120 mg twice daily, with a median follow-up of about six years (DeKosky et al., 2008). The European GuidAge trial enrolled nearly 2,900 people and ran for five years (Vellas et al., 2012).

These are numbers that barely exist in the supplement world. When somebody asks "is it safe to take this for a year", the answer rests on a dataset where people took the same thing for five to six years under medical supervision, with every adverse event documented.

One important caveat: both trials used a standardised leaf extract, not dried leaf powder and not seeds. The safety data apply to that specific extract, not to everything with the word "ginkgo" on the label. We come back to that below.

What the long trials showed about safety

The short version: those trials did not show an increase in serious adverse events in the ginkgo group compared with placebo. Mortality, stroke and cardiac events and hospitalisations did not differ in a way that would have stopped the trial (DeKosky et al., 2008; Vellas et al., 2012).

This does not mean there are no side effects. The common complaints are mild and familiar from any plant extract: headache, nausea, digestive upset, more rarely an allergic skin reaction. They typically appear in the first weeks, not after years.

The second thing worth saying honestly: the participants in those trials were mostly older adults. Data on a 25-year-old taking ginkgo through an exam period are much weaker - simply because nobody has followed those people for six years. A safety profile that holds in a 75-year-old is generally a conservative estimate for a younger person too, but that is an inference rather than a measurement.

What ginkgo did not do in those trials

An honest review has to state this side as well. The main result of GEM was that ginkgo did not reduce the incidence of dementia over the follow-up period (DeKosky et al., 2008), and the follow-up analysis found no slowing of cognitive decline either (Snitz et al., 2009). GuidAge reached a similar result over five years (Vellas et al., 2012). A Cochrane review concluded that the evidence is inconsistent and unreliable (Birks & Grimley Evans, 2009).

Why does that matter in a safety article? Because safety and worthwhileness are two different questions. Something can be perfectly safe and still be a waste of money. If you are weighing up years of ginkgo, the honest starting point is that large long-term trials did not show the benefit the marketing implies, and that the best thing you can say is "well tolerated".

The bleeding story: where it came from and what the data say

The most common warning online is that ginkgo thins the blood. Behind it there is a real mechanism - ginkgolides affect platelet-activating factor - and a series of individual case reports of bleeding in people taking ginkgo.

When the question was looked at systematically, however, the picture was different. A meta-analysis of randomised trials found no statistically significant increase in bleeding risk with standardised ginkgo extract (Kellermann & Kloft, 2011). The signal did not emerge in the large long-term trials either.

The practical conclusion is not "there is nothing to think about" but something more precise: for an average healthy person this is not a risk to fear; for someone already on blood-thinning medication, or facing surgery or a dental procedure, caution is sensible. The usual advice is to stop herbal extracts about two weeks before planned surgery and to tell the surgeon what you take. That is not a ginkgo-specific rule, it is general good practice in surgery.

Drug interactions

Ginkgo affects certain liver enzymes that metabolise medicines, which is why the list of theoretical interactions is longer than the list of practical ones (Unger, 2013). Groups that should talk to a doctor before starting:

• Blood thinners and antiplatelet agents. The single most important group.
• Anti-epileptic drugs. Ginkgo seeds contain a compound that is problematic for seizure threshold; leaf extract contains little of it, but caution is justified.
• Antidepressants and sedatives. The interactions are mostly theoretical, but this is not a group where self-experimentation is a good idea.
• Diabetes medication. Monitoring blood glucose after starting is a reasonable precaution.

And one simple rule that applies to every supplement: if you take a prescription medicine daily, adding a supplement is a conversation with your GP, not a decision you make in front of a shop shelf. We cover this in depth in a separate article on ginkgo interactions.

Standardisation: why all ginkgo products are not the same thing

This is where trial results get transferred incorrectly most often. The large trials used a leaf extract standardised to a defined content of flavonoid glycosides and terpene lactones. If the jar contains ground leaf with no standardisation instead, it is not the same product, and neither the safety nor the tolerability data transfer directly.

A practical checklist before buying:

1. Does the label state an extract ratio or a standardisation percentage, rather than just "ginkgo 500 mg"?
2. Is it a leaf extract rather than a seed extract?
3. Does the daily dose stay within the range used in trials (typically 120-240 mg of standardised extract per day)?

In the European Union ginkgo occupies two different regulatory roles: some preparations are registered as herbal medicinal products, others are sold as food supplements. In Estonia that means the ginkgo sold in a pharmacy and the ginkgo sold in a sports nutrition shop are not necessarily the same category of product, even though both jars carry the same plant name. A registered medicinal preparation faces stricter composition requirements. With a food supplement, reading the label is the buyer's own job. We look at the differences between forms more closely in the article on ginkgo forms.

Doses and duration: what the trials used

The table shows that 240 mg a day is the ceiling for which long-term data exist. Higher doses are not better studied, and "more is better" has no basis here.

Is cycling necessary?

A common recommendation is to take ginkgo for three months and then take a month off. There is no direct trial evidence behind it: the long-term studies used continuous dosing for years with no breaks, and no breaks were built in for safety reasons.

A break can still make practical sense, but for a different reason. If you take something continuously, you never learn whether it does anything. Four weeks off after three months on is a cheap way to check whether you notice a difference. If you do not, you have just saved a year of spending. Most people do not notice - and that is an entirely honest result, not a failure.

We have a separate article on timing and splitting the dose, on when to take ginkgo.

How to check whether it does anything for you

The decision about long-term use becomes much easier once you have even a crude measure. Most people judge a supplement by memory, which is the worst possible instrument: a month later, what you mostly remember is that you were expecting some kind of change.

The practical fix is to write down one specific thing you will track before you start, and to rate it once a week on a scale of one to five. For example: how clear your head is around three in the afternoon; how intrusive tinnitus is in the evening; how quickly you get into work in the morning. One thing, not five. Also note the days when you slept under six hours or were ill, because those explain most of the fluctuation without any capsule being involved.

After eight weeks, look at the rows. If the average sits where it started, you have your answer and it cost you one jar. If there is a difference, take a four-week break and see whether the number falls back. That is as close to a personal controlled test as a home kitchen allows, and it is more honest than any product review online - including the one you are reading.

Why this matters specifically for ginkgo: since the large trials showed no clear benefit at group level, the only thing that still counts is whether you personally notice something. If you do not, the product is neither bad nor dangerous for you - it is simply a line of expenditure.

Who should skip ginkgo

• Anyone on blood-thinning therapy, without clearing it with their doctor.
• Anyone with surgery or a dental procedure planned in the next two weeks.
• People with epilepsy. The theoretical risk around seizure threshold makes unsupervised use unwise for this group.
• Pregnant and breastfeeding women. Data are lacking, which means a default no.
• Children and adolescents. The trials were done in adults, predominantly older adults.
• Anyone expecting a clear improvement in memory. The large long-term trials did not show it, and a realistic expectation is the single most important safety measure here.

A practical protocol for long-term use

1. Start at the low end. 120 mg of standardised extract per day is the bottom of the studied range and a sensible starting point.
2. Give it eight to twelve weeks before deciding. If nothing has changed, week sixteen will not change it either.
3. Take it with food if nausea appears. That is the most common tolerability issue and it usually resolves this way.
4. Write down what you are tracking. Sleep quality, focus, tinnitus - one specific thing, not general wellbeing. Without it there is nothing to evaluate.
5. Tell your doctor if you start alongside prescription medicines, and certainly before any surgery.
6. Review every three months whether you are paying for something you actually notice.

The Estonian shelf for ginkgo is thin - the cognitive support category here is considerably smaller than, say, the protein or creatine selection. At the time of writing our category holds two products: MST Ginkgo Biloba 60 caps at 16,90 € and the cheaper powdered OstroVit Ginkgo Biloba Extract 50g at 12,90 €. At one capsule a day the MST jar works out at about 0,28 € per day and lasts roughly two months; the powder is cheaper but you have to weigh and measure the dose yourself. The full selection is in the ginkgo biloba category.

What is worth fixing before ginkgo

This is the least popular part of the article. If the goal is a clearer head, the things that deliver more than any plant extract are boring: sleep, ruling out iron or B12 deficiency with a blood test, alcohol intake and eating enough. During the dark half of the Estonian year, vitamin D status joins that list.

Adequate protein belongs in the same boring list, particularly for older adults, whose daily protein intake tends to fall short. If that is your bottleneck, the cheapest way to cover it is ordinary whey powder: BIOTECHUSA 100% Pure Whey Apple Pie 454g costs 19,90 € and Optimum Nutrition Gold Standard 100% Whey 450g Vanilla Ice Cream costs 24,90 €. For basic vitamin cover we have a separate vitamin complexes category.

Ginkgo is the last line on that list, not the first. That is also why the question of long-term use is as much a budget question as a safety question.

Verdict

Standardised ginkgo leaf extract is one of the few supplements with multi-year controlled safety data, and that data is reassuring: up to 240 mg a day for five to six years did not bring an increase in serious adverse events, and the bleeding fear was not confirmed in systematic analysis.

The same trials also tell the other half of the story: they did not show the benefit they were looking for. So long-term use is safe rather than risky, but that does not make it worthwhile. If you take it and notice something specific, continuing is reasonable. If you take it "just in case", a three-month break is the most honest test you can run yourself.

The caution applies to one group only and it bears repeating: blood-thinning therapy, planned surgery, epilepsy or pregnancy mean this decision goes through a doctor.

FAQ

Can ginkgo be taken for years on end?

In large clinical trials, standardised extract was taken continuously for five to six years with no increase in serious adverse events. That is the best available answer, and it applies to standardised leaf extract at the studied dose.

Does ginkgo thin the blood?

The mechanism exists, but a meta-analysis of randomised trials found no significant increase in bleeding risk. Even so: alongside blood-thinning therapy or before surgery, this decision goes through a doctor.

Do I have to cycle it?

There is no trial evidence for a need to take breaks. A break is useful for a different reason - it is the only way to find out whether the product does anything for you.

How much is too much?

Long-term data extend to 240 mg per day. Higher doses are not better studied and no additional benefit has been shown.

Is pharmacy ginkgo the same as a supplement?

Not necessarily. Some preparations are registered as herbal medicinal products with stricter composition requirements, others are food supplements. Read the label for whether the extract is standardised, and at what dose.

How long should I wait before deciding?

Eight to twelve weeks. If nothing specific has changed in that time, longer use will not change the outcome.

References

Birks, J., & Grimley Evans, J. (2009). Ginkgo biloba for cognitive impairment and dementia. Cochrane Database of Systematic Reviews, (1), CD003120.

DeKosky, S. T., Williamson, J. D., Fitzpatrick, A. L., et al. (2008). Ginkgo biloba for prevention of dementia: a randomized controlled trial. JAMA, 300(19), 2253-2262. https://pubmed.ncbi.nlm.nih.gov/19017911/

Kellermann, A. J., & Kloft, C. (2011). Is there a risk of bleeding associated with standardized Ginkgo biloba extract therapy? A systematic review and meta-analysis. Pharmacotherapy, 31(5), 490-502. https://pubmed.ncbi.nlm.nih.gov/21923430/

Snitz, B. E., O'Meara, E. S., Carlson, M. C., et al. (2009). Ginkgo biloba for preventing cognitive decline in older adults: a randomized trial. JAMA, 302(24), 2663-2670. https://pubmed.ncbi.nlm.nih.gov/20040554/

Unger, M. (2013). Pharmacokinetic drug interactions involving Ginkgo biloba. Drug Metabolism Reviews, 45(3), 353-385. https://pubmed.ncbi.nlm.nih.gov/23865865/

Vellas, B., Coley, N., Ousset, P. J., et al. (2012). Long-term use of standardised Ginkgo biloba extract for the prevention of Alzheimer's disease (GuidAge): a randomised placebo-controlled trial. The Lancet Neurology, 11(10), 851-859. https://pubmed.ncbi.nlm.nih.gov/22959217/